Skip to content

Role of Marichadi Gutika and Mandookparni vati in the management of Irritable Bowel Syndrome in Children

A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL ON THE EFFICACY OF MARICHADI GUTIKA AND MANDOOKPARNI VATI IN THE MANAGEMENT OF IBS IN CHILDREN - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100562
Enrollment
60
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K909- Intestinal malabsorption, unspecified

Interventions

None listed

Sponsors

State Ayurvedic college and hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)patients having age between 6-12yr ,irrespective of sex,religion,occupational and socio-economic status 2)patient having more than or equal to 50% of subjective parameter will be included in the study. 3)Having history of recurrent abdominal pain at least 2 month before diagnosis. 4)History of evacuation after taking meal. 5)patient willing to participate in the research trial.

Exclusion criteria

Exclusion criteria: 1)Patients having age below 6 year and above 12year. 2)Red Flag in Diagnosing IBS -Confirmed weight loss -Symptoms persistent or worse at night (child wakes up with pain) -Unexplained anemia -Bleeding per rectum. -Severe diarrhea and/or vomiting -Unexplained fever -Strong family history of inflammatory bowel disease 3)Children having already history of metabolic disorders and systemic disorder like TB, DM etc. will be excluded from the study. 4)Children suffering from congenital anomalies, acute infectious disease

Design outcomes

Primary

MeasureTime frame
1) Improvement in condition of children. 2) Improvement frequency/consistency of stool in 15 days of trial. 3)Improvement in abdominal pain. Timepoint: after 15th days of complete clinical trial

Secondary

MeasureTime frame
To evaluate the efficacy of marichadi gutika and mandookparni vatiTimepoint: After completing the 15th day of trial

Countries

India

Contacts

Public ContactDr Laxmi

State Ayurvedic college and hospital Lucknow

lakshmiomsingh@gmail.com9792446688

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026